Implantable cardioverter-defibrillators in congenital heart disease - adult congenital disease heart in option pacing patient


adult congenital disease heart in option pacing patient

The 2014 Pediatric & Congenital Electrophysiology Society (PACES)/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease 12 addresses itself to anticoagulation as a treatment for atrial arrhythmias. The guidelines recommend vitamin K antagonists in moderate-to-complex cases of CHD Author: Wilson W. Lam.

A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Cited by: 18.

Jun 01, 2016 · Implantable cardioverter-defibrillators (ICD) have an important role in reducing sudden cardiac death in patients with congenital heart disease (CHD); however, the benefit of ICDs needs to be weighed up against both short-term and long-term adverse effects, which are difficult to evaluate in the heterogeneous CHD population.Cited by: 2.